Basal Insulin for Type 2 Diabetes Patients Treated in Outpatient Clalit Clinics
NCT00726674 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1229
Last updated 2012-03-08
Summary
Treatment of diabetes mellitus type II with basal insulin, for patients treated in Clalit outpatient clinics that are not adequately controlled with current treatment.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Nurit Tweezer-Zaks · Sanofi
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2012-01-31
- Completion
- 2012-01-31
Countries
- Israel
Study Locations
More Related Trials
-
Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan
NCT02606357 ·Status: COMPLETED ·Phase: PHASE4
-
Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment
NCT00046462 ·Status: COMPLETED ·Phase: PHASE3
-
Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)
NCT00627471 ·Status: TERMINATED ·Phase: PHASE4
-
Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus
NCT00565162 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice
NCT00576368 ·Status: COMPLETED ·Phase: PHASE4
-
Simplified Insulin Protocol Using Lantus in Elderly
NCT01480843 ·Status: COMPLETED ·Phase: PHASE4
-
Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial)
NCT00390728 ·Status: COMPLETED ·Phase: PHASE4
-
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
NCT00330473 ·Status: COMPLETED ·Phase: PHASE3
-
Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin
NCT00338104 ·Status: COMPLETED ·Phase: PHASE4
-
Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes
NCT00174681 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2)
NCT00659477 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus Patients
NCT03352674 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin
NCT00693771 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Adults With Type 1 Diabetes
NCT01421147 ·Status: COMPLETED ·Phase: PHASE3
-
Insulin Glargine in Type 2 Diabetes
NCT00268645 ·Status: COMPLETED ·Phase: PHASE4
-
Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine)
NCT00653302 ·Status: COMPLETED ·Phase: PHASE4
-
Insulin Glulisine in Diabetes Mellitus, Type 2
NCT00174668 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006)
NCT00511472 ·Status: COMPLETED ·Phase: PHASE1
-
Lantus in Prediabetes
NCT00348972 ·Status: COMPLETED ·Phase: PHASE1
-
Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)
NCT00642915 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin
NCT01499082 ·Status: COMPLETED ·Phase: PHASE3
-
The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes
NCT00366301 ·Status: TERMINATED ·Phase: PHASE4
-
Beta Cell Relieving and Cardiovascular Protective Effects of LANTUS Treatment in Type 2 Diabetes Patients
NCT01206712 ·Status: COMPLETED
-
A Study in Adults With Type 2 Diabetes
NCT01421459 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying
NCT01910194 ·Status: COMPLETED ·Phase: PHASE2